Bevacizumab and atezolizumab as first-line therapy for advanced hepatocellular carcinoma: A Taiwanese subgroup analysis on efficacy and safety
| Title: | Bevacizumab and atezolizumab as first-line therapy for advanced hepatocellular carcinoma: A Taiwanese subgroup analysis on efficacy and safety |
|---|---|
| Authors: | Shao, Yu-Yun, Feng, Yin-Hsun, Yen, Chia-Jui, Yang, Tsai-Sheng, Shen, Ying-Chun, Chao, Yee, Chen, Jen-Shi, Su, Ching-Yen, Chen, Wei-Jen, Hsiang, Hwa-Lin, Hsu, Chih-Hung |
| Source: | In Journal of the Formosan Medical Association December 2022 121(12):2430-2437 |
| Database: | ScienceDirect |
| ISSN: | 09296646 |
|---|---|
| DOI: | 10.1016/j.jfma.2022.09.005 |
| Published in: | Journal of the Formosan Medical Association |
| Language: | English |